Product Images Rocuronium Bromide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Rocuronium Bromide NDC 0409-7037 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

rocuronium-spl-carton-100-mg - rocuronium spl carton 100 mg

rocuronium-spl-carton-100-mg - rocuronium spl carton 100 mg

This is a description of a medical product called Rocuronium Bromide Injection. It is a sterile and nonpyrogenic solution used for intravenous use. Each milliliter of the solution contains 10 mg of rocuronium bromide and 2 mg of sodium acetate, adjusted to isotonicity and a pH of 4. It is important to note that this solution is a paralyzing agent and can cause respiratory arrest, so facilities must have artificial respiration capabilities available. The product should be stored under refrigeration between 2 to 8°C (36 to 46°F) and should not be frozen. Once removed from refrigeration, it can be stored at room temperature (25°C/77°F) for up to 60 days. Opened vials should be used within 30 days. The packaging of this product is not made with natural rubber latex. It is distributed by Hospira, Inc. and made in India. The product is sold in 100 mg/10 mL vials, with 10 vials in a package. The product is for intravenous use only and is available by prescription only.*

rocuronium-spl-carton-50-mg - rocuronium spl carton 50 mg

rocuronium-spl-carton-50-mg - rocuronium spl carton 50 mg

This text appears to be a description of a medication called Rocuronium Bromide Injection. It is a sterile, nonpyrogenic solution that is used as a paralyzing agent during medical procedures. The usual dosage is specified in the package insert. Each mL of the solution contains 10 mg of rocuronium bromide and 2 mg of sodium acetate. The pH of the solution is adjusted to 4 using acetic acid and/or sodium hydroxide. The text also warns that the medication can cause respiratory arrest, so facilities for artificial respiration should be immediately available. It should be stored under refrigeration and not frozen. Once removed from refrigeration, it should be used within 60 days. Once opened, vials should be used within 30 days. The packaging does not contain natural rubber latex. The product is made in India and distributed by Hospira, Inc. in the USA. The medication is for intravenous use only. The NDC code for this product is 0409-3189-10. The product comes in 10 x 5 mL multiple dose vials.*

rocuronium-spl-fig-1 - rocuronium spl fig 1

rocuronium-spl-fig-1 - rocuronium spl fig 1

rocuronium-spl-fig-2 - rocuronium spl fig 2

rocuronium-spl-fig-2 - rocuronium spl fig 2

rocuronium-spl-fig-3 - rocuronium spl fig 3

rocuronium-spl-fig-3 - rocuronium spl fig 3

rocuronium-spl-fig-4 - rocuronium spl fig 4

rocuronium-spl-fig-4 - rocuronium spl fig 4

rocuronium-spl-structure - rocuronium spl structure

rocuronium-spl-structure - rocuronium spl structure

rocuronium-spl-vial-100-mg - rocuronium spl vial 100 mg

rocuronium-spl-vial-100-mg - rocuronium spl vial 100 mg

rocuronium-spl-vial-50-mg - rocuronium spl vial 50 mg

rocuronium-spl-vial-50-mg - rocuronium spl vial 50 mg

This text provides information about a medication called Rocuronium Bromide Injection. It is a paralyzing agent that is intended for intravenous use only. The medication comes in a 5 mL multiple dose vial, with a concentration of 50 mg/5 mL (10 mg/mL). It is important to note that this medication can cause respiratory arrest, so facilities must have artificial respiration capabilities readily available. The medication should be stored in a refrigerator between 2 to 8°C (36 to 46°F) and should not be frozen. Once removed from the refrigerator, it should be used within 60 days if stored at room temperature (25°C/77°F) and within 30 days for opened vials. The product packaging does not contain natural rubber latex. The medication is distributed by Hospira, Inc. located in Lake Forest, IL, USA.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.